γδ T-cell Receptor (γδ-TCR)

Online Inquiry

Introduction of γδ T-cell Receptor

Divided by the T-cell receptor (TCR) expressed on the cell surface, T lymphocytes are generally categorized into αβ T cells and γδ T cells. The human γδ T cell is a minor population of T lymphocytes carrying a distinctive γδ T-cell receptor (γδ-TCR). Although only accounting for ~5% of the total T cells, γδ T cells play an important function in both innate and adaptive immune responses.

The featured γδ-TCR expressed by γδ T cell is a membrane-anchored heterodimeric protein composed of two variable peptide chains: γ chain and δ chain, together with the cluster of differentiation 3 (CD3), forming the TCR complex to mediate signal transduction. The γ chain and δ chain are linked by a disulfide bond, each of which can be divided into a variable (V) region away from the membrane and a constant (C) region near the membrane. The complementarity-determining regions (CDRs) locate at the top of the γ chain and δ chain, providing a highly variable antigen-binding domain, which plays a decisive role in antigen recognition and effector functions of γδ T cell.

Diversity of γδ T-cell Receptor (γδ-TCR)

The γ chain and δ chain that make up the γδ-TCR are encoded by the multiple variable (V), diversity (D, only inδ chain), and joining (J) gene segments. The diversity of γδ-TCR is rightly determined by the ordered V(D)J-recombination. Four human γδ T cell populations, there are about 4-6 Vγ and 8 Vδ gene segments, among which Vδ1, Vδ2, Vδ3, and Vγ2, Vγ3, Vγ4, Vγ5, Vγ8, Vγ9, and Vγ11 are the most frequently gene segments used in the γδ-TCR rearrangement. The different TCR γ chains combining with δ chains forms featured γδ-TCRs defining different γδ T cell subtypes, such as Vγ9Vδ2 T cells expressing the TCR rearranged by a Vγ9 chain and a Vδ2 chain, and account for the majority of peripheral blood γδT cells.

V(D)J recombination at the TCR-γ (upper panel) and TCRα/TCRδ (lower panel) locus.Fig.1 V(D)J recombination at the TCR-γ (upper panel) and TCRα/TCRδ (lower panel) locus.1

Targets Recognized by γδ-TCR

With a structure similar to immunoglobulin, γδ-TCR can recognize and respond to a variety of self- and nonself- molecules. Compared with the large quantity of identified ligands recognized by αβ T cells, currently confirmed ligands for human γδ TCR are relatively scarce. Importantly, γδ TCR-mediated recognition is an unrestricted major histocompatibility complex (MHC), which is completely different from αβ T cells. The targets or antigens recognized by γδ-TCR mainly encompass but are not limited to phosphoantigens, MHC molecules, CD1 family molecules, soluble proteins, and many other structures. By binding to these targets, γδ T cells are activated and induce a diversity of biological functions, exerting a fundamental effect in immune defense and surveillance.

Different classes of proposed and confirmed γδ T cell ligands.Fig.2 Different classes of proposed and confirmed γδ T cell ligands.2,4

γδ T Cell Receptor Repertoire in Human Health

In humans, γδ T cells arise in the thymus from the fetal age, maintaining throughout lifetime after birth and closely involving human health and diseases. Early in gestation, both Vδ1+ and Vδ2+ TCRs, dominantly Vδ2+ TCRs, can be detected in the fetal blood. After birthing in the thymus, immature γδ T cells with Vδ1+ TCRs are the most abundant, which subsequently leave the thymus to differentiate into effector γδ T cells in the periphery. In healthy adults, circulating Vγ9Vδ2+ T cells dominate, whereas, when challenged by environmental stimuli Vδ1+ T cells rapidly expand. Additionally, these γδ T cells with specific γδ-TCR distributed in different tissues are not identical. The γδ TCR repertoire composition on the surface of γδ T cells is representative of a healthy or diseased state. Currently, γδ TCR repertoire analysis has been widely applied for the exploration and elaboration of the relationship between the γδ T cell and human diseases.

Developmental waves of human γδ T cells.Fig.3 Developmental waves of human γδ T cells.3,4

References

  1. Legut, Mateusz, David K. Cole, and Andrew K. Sewell. "The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy." Cellular & molecular immunology 12.6 (2015): 656-668. Distributed under Open Access license CC BY 3.0, without modification.
  2. Vermijlen, David, et al. "γδ T cell responses: How many ligands will it take till we know?." Seminars in cell & developmental biology. Vol. 84. Academic Press, 2018.
  3. Fichtner, Alina Suzann, Sarina Ravens, and Immo Prinz. "Human γδ TCR repertoires in health and disease." Cells 9.4 (2020): 800.
  4. Distributed under Open Access license CC BY 4.0, without modification.
All listed services and products are for research use only. Do not use in any diagnostic or therapeutic applications.

Online Inquiry